Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

Recruiting now

Conditions studied: Pediatric Cancer

In brief

It involves collecting safety and efficacy data, under the actual conditions of use of off label and compassionate use medicines in children and adolescents approved in humans before 2007, using a validated tool (Ennov EDC) and relying on the network recognised pediatric hemato-oncology centers in Belgium and responsible for the organization of Pediatric National tumor boards which discuss each case of relapse in order to define the best therapeutic options.

Key facts

Study ID
NCT07727694
Run by
Universitaire Ziekenhuizen KU Leuven
People needed
1600
Starts
2026-07-01
Expected to finish
2030-12-31
Last updated by the study team
2026-07-27

Who can join

Age: any, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.